Plant-based meat
-
DATABASE (852)
-
ARTICLES (622)
Founded in Boston in 2015, Material Impact is a science-based investment fund backing products that make an impact on real-world problems. It currently has 10 companies in its portfolio, from seed to Series C investments. Its most recent investments have been in the $50m 2020 Series C round of SOURCE Global (formerly Zero Mass Water), the premier off-grid drinking water production tech using solar-powered panels, and in the 2020 $12m Series A round of US electronics protective substance producer actnano.
Founded in Boston in 2015, Material Impact is a science-based investment fund backing products that make an impact on real-world problems. It currently has 10 companies in its portfolio, from seed to Series C investments. Its most recent investments have been in the $50m 2020 Series C round of SOURCE Global (formerly Zero Mass Water), the premier off-grid drinking water production tech using solar-powered panels, and in the 2020 $12m Series A round of US electronics protective substance producer actnano.
Enagás Emprende, part of the Spanish Transmission System Operator (TS) Enagás, is an investment venture backing and accelerating technology-based startups in their scale-up phase. Its portfolio investment mainly includes companies providing renewable gases, green hydrogen, and biomethane, but also sustainable mobility and energy efficiency. With 50 years of experience in energy infrastructures across Spain, the US, Mexico, Chile, Peru, Albania, Greece and Italy, Enagás provides its portfolio startups with mentoring and expertise acting as investors, clients and industry partners.
Enagás Emprende, part of the Spanish Transmission System Operator (TS) Enagás, is an investment venture backing and accelerating technology-based startups in their scale-up phase. Its portfolio investment mainly includes companies providing renewable gases, green hydrogen, and biomethane, but also sustainable mobility and energy efficiency. With 50 years of experience in energy infrastructures across Spain, the US, Mexico, Chile, Peru, Albania, Greece and Italy, Enagás provides its portfolio startups with mentoring and expertise acting as investors, clients and industry partners.
Hong Kong-based Unicorn Capital Partners was founded in 2015 by Tommy Yip, former partner of Emerald Hill Capital Partners.Unicorn is a leading FoF platform that focuses on venture capital fund and direct investment opportunities in China and Asia. It mainly invests in technology, media, telecommunications and healthcare. By December 2019, Unicorn had $800m in assets under management. It also raised over $350m for its fourth fund.
Hong Kong-based Unicorn Capital Partners was founded in 2015 by Tommy Yip, former partner of Emerald Hill Capital Partners.Unicorn is a leading FoF platform that focuses on venture capital fund and direct investment opportunities in China and Asia. It mainly invests in technology, media, telecommunications and healthcare. By December 2019, Unicorn had $800m in assets under management. It also raised over $350m for its fourth fund.
UBS is a Switzerland-based financial institution providing banking, wealth management, and securities services. Originally established in 1862 as the Bank in Winterthur, it is the largest Swiss banking institution. UBS engages in venture capital activities as part of its investment banking services. In 2020, UBS began a partnership with venture capital firm Anthemis to launch UBS Next, a $200m fund that will invest in fintech and other tech startups.
UBS is a Switzerland-based financial institution providing banking, wealth management, and securities services. Originally established in 1862 as the Bank in Winterthur, it is the largest Swiss banking institution. UBS engages in venture capital activities as part of its investment banking services. In 2020, UBS began a partnership with venture capital firm Anthemis to launch UBS Next, a $200m fund that will invest in fintech and other tech startups.
Based in New York City, Lerer Hippeau mainly invests in seed and early-stage startups based in the US. Founded in 2010 by managing partners Kenneth Lerer, Ben Lerer and Eric Hippeau, the VC operates several funds offering initial investments of $1m per startup. Kenneth Lerer is the co-founder of Huffington Post and longtime chairman of BuzzFeed. Hippeau was the CEO of Huffington Post and ex-managing partner of Softbank Capital that invested in Huffington Post.Its 400+ startups also get support for business growth by tapping into tech ecosystems like New York, San Francisco and Los Angeles. Its 80+ exits include Giphy (GIF) that was acquired by Facebook and home-fitness studio Mirror acquired by Lululemon. However, the IPO by portfolio company Bed-in-a-box online retailer Casper was below market expectations. The loss-making e-commerce unicorn went public at $12 a share in February 2020, closing at $13.50 on its first day out, for a market capitalization of less than half the $1.1 billion Casper was valued at in a private funding round in 2019.
Based in New York City, Lerer Hippeau mainly invests in seed and early-stage startups based in the US. Founded in 2010 by managing partners Kenneth Lerer, Ben Lerer and Eric Hippeau, the VC operates several funds offering initial investments of $1m per startup. Kenneth Lerer is the co-founder of Huffington Post and longtime chairman of BuzzFeed. Hippeau was the CEO of Huffington Post and ex-managing partner of Softbank Capital that invested in Huffington Post.Its 400+ startups also get support for business growth by tapping into tech ecosystems like New York, San Francisco and Los Angeles. Its 80+ exits include Giphy (GIF) that was acquired by Facebook and home-fitness studio Mirror acquired by Lululemon. However, the IPO by portfolio company Bed-in-a-box online retailer Casper was below market expectations. The loss-making e-commerce unicorn went public at $12 a share in February 2020, closing at $13.50 on its first day out, for a market capitalization of less than half the $1.1 billion Casper was valued at in a private funding round in 2019.
Founded and headed by Susan Choe in 2018, Katalyst Ventures is based in San Francisco with a debut fund of $34m raised in 2018. Choe is also a partner at another Zipline investor Visionnaire Ventures (VV) also based in Silicon Valley. Katalyst invests in seed and early-stage tech startups with human-centric solutions. About 45% of the VC funds are invested in startups with women as CEO or CTO. By February 2020, the Kalatyst portfolio included 22 enterprises and three exits.The founder of Outspark was removed as CEO by the board of directors due to disagreements over the sale of Outspark. She had used her own money in 2006 to create Outspark, a data-driven publishing platform for game developers. Outspark was eventually sold to Axel Springer and Choe went left the company to join Taizo Son’s venture capital group. In 2013, VV was set up to support tech startups in the US. Choe had worked for Yahoo! and also was the COO of the public-listed holding company of South Korean search and media company NHN.
Founded and headed by Susan Choe in 2018, Katalyst Ventures is based in San Francisco with a debut fund of $34m raised in 2018. Choe is also a partner at another Zipline investor Visionnaire Ventures (VV) also based in Silicon Valley. Katalyst invests in seed and early-stage tech startups with human-centric solutions. About 45% of the VC funds are invested in startups with women as CEO or CTO. By February 2020, the Kalatyst portfolio included 22 enterprises and three exits.The founder of Outspark was removed as CEO by the board of directors due to disagreements over the sale of Outspark. She had used her own money in 2006 to create Outspark, a data-driven publishing platform for game developers. Outspark was eventually sold to Axel Springer and Choe went left the company to join Taizo Son’s venture capital group. In 2013, VV was set up to support tech startups in the US. Choe had worked for Yahoo! and also was the COO of the public-listed holding company of South Korean search and media company NHN.
COO and co-founder of iLoF
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Media Digital Ventures is the first Spanish Cross-Media fund focusing on Media for Equity. It holds multichannel advertising assets across major media sectors. Based in Barcelona, MDV also creates multimedia and advertising campaigns for scaling high-growth startups in return for equity.MDV is co-founded by Gerard Olivé and Miguel Vicente. Both are serial entrepreneurs, investors and co-founders of Antai Venture Builder, Wallapop, Deliberry and Chicplace. Vicente, who exited LetsBonus which he founded in 2009, is also the president of Barcelona Tech City.
Media Digital Ventures is the first Spanish Cross-Media fund focusing on Media for Equity. It holds multichannel advertising assets across major media sectors. Based in Barcelona, MDV also creates multimedia and advertising campaigns for scaling high-growth startups in return for equity.MDV is co-founded by Gerard Olivé and Miguel Vicente. Both are serial entrepreneurs, investors and co-founders of Antai Venture Builder, Wallapop, Deliberry and Chicplace. Vicente, who exited LetsBonus which he founded in 2009, is also the president of Barcelona Tech City.
Partech Ventures is a global venture capital firm established in San Francisco in 1982 as Paribas Technologies, a subsidiary of French bank Paribas that currently holds €1.3 billion in assets under its management. In addition to San Francisco, Partech also has offices in Paris, Berlin and Dakar, Senegal, with the latter focused exclusively on African startups. The company is now based in Paris and has invested in over 300 companies across different funding stages with 48 exits to date.
Partech Ventures is a global venture capital firm established in San Francisco in 1982 as Paribas Technologies, a subsidiary of French bank Paribas that currently holds €1.3 billion in assets under its management. In addition to San Francisco, Partech also has offices in Paris, Berlin and Dakar, Senegal, with the latter focused exclusively on African startups. The company is now based in Paris and has invested in over 300 companies across different funding stages with 48 exits to date.
Qingdao Haier Venture Capital is the investment arm of China-based electronics manufacturer Haier Group. The Haier SAIF fund was established in September 2014, in partnership with private equity firm SAIF Partners and other investors. The RMB 320m investment fund is managed by SAIF Partners. The fund mainly invests smart home product developers and related sectors like AI, IoT and big data. As of December 2017, it has invested in 16 startups.
Qingdao Haier Venture Capital is the investment arm of China-based electronics manufacturer Haier Group. The Haier SAIF fund was established in September 2014, in partnership with private equity firm SAIF Partners and other investors. The RMB 320m investment fund is managed by SAIF Partners. The fund mainly invests smart home product developers and related sectors like AI, IoT and big data. As of December 2017, it has invested in 16 startups.
Hong Kong-based Jeneration Capital was founded in 2015 by Jimmy Chang, a former banker at Morgan Stanley. It now manages approximately US$2bn in capital, utilizing a multi-strategy investment approach with an emphasis on direct investment and dynamic asset allocation across private equity, public equity and diversified fund investments. In terms of direct investment, Jeneration Capital mainly invests in growth-stage technology-enabled companies in the Asia-Pacific region, with a focus on Greater China.
Hong Kong-based Jeneration Capital was founded in 2015 by Jimmy Chang, a former banker at Morgan Stanley. It now manages approximately US$2bn in capital, utilizing a multi-strategy investment approach with an emphasis on direct investment and dynamic asset allocation across private equity, public equity and diversified fund investments. In terms of direct investment, Jeneration Capital mainly invests in growth-stage technology-enabled companies in the Asia-Pacific region, with a focus on Greater China.
Singapore-based VC Jungle Ventures set up its SeedPlus fund in 2016. The SGD 25m fund is backed by a diverse range of investors including Eight Roads, Infocomm Investments, Accel Partners, RNT Associates, SGInnovate and Cisco. A fund run by Jungle Ventures partner and Indian tycoon Ratan Tata has also contributed to SeedPlus.Early-stage investments of SGD 0.5–1m are available for startups in Southeast Asia. The fund also provides hands-on expertise and support services, including resources from partners like Google SEA and PwC Singapore.
Singapore-based VC Jungle Ventures set up its SeedPlus fund in 2016. The SGD 25m fund is backed by a diverse range of investors including Eight Roads, Infocomm Investments, Accel Partners, RNT Associates, SGInnovate and Cisco. A fund run by Jungle Ventures partner and Indian tycoon Ratan Tata has also contributed to SeedPlus.Early-stage investments of SGD 0.5–1m are available for startups in Southeast Asia. The fund also provides hands-on expertise and support services, including resources from partners like Google SEA and PwC Singapore.
Shanghai-based Shengyin Incubation is a wholly-owned subsidiary of Shengyin Investment, specialized in private equity investment, merger & acquisition, investment consultancy and startup incubation. It invests mainly in early-stage startups in agritech, new retail, education and enterprise services. Shengyin Incubation is also eyeing commercial opportunities brought by new technologies such as AI, blockchain and IoT. Since its establishment in 2006, Shengyin Incubation has invested in over 100 startups, of which 26 have been listed on China's stock exchanges in Shanghai and Shenzhen.
Shanghai-based Shengyin Incubation is a wholly-owned subsidiary of Shengyin Investment, specialized in private equity investment, merger & acquisition, investment consultancy and startup incubation. It invests mainly in early-stage startups in agritech, new retail, education and enterprise services. Shengyin Incubation is also eyeing commercial opportunities brought by new technologies such as AI, blockchain and IoT. Since its establishment in 2006, Shengyin Incubation has invested in over 100 startups, of which 26 have been listed on China's stock exchanges in Shanghai and Shenzhen.
Big Sur Ventures is a Spanish VC based in Madrid. It was co-founded by Jose Miguel Herrero and Manuel Matés both with extensive international experience in leading technology products and services companies and M&A. The fund invests in companies focused on SaaS, online marketplace and platforms, IT and digital media. Investments range from seed to later growth stage. The VC usually represents the first institutional capital in a company, leading or co-leading the round with capital injection of between €100,000 and €400.000 per round.
Big Sur Ventures is a Spanish VC based in Madrid. It was co-founded by Jose Miguel Herrero and Manuel Matés both with extensive international experience in leading technology products and services companies and M&A. The fund invests in companies focused on SaaS, online marketplace and platforms, IT and digital media. Investments range from seed to later growth stage. The VC usually represents the first institutional capital in a company, leading or co-leading the round with capital injection of between €100,000 and €400.000 per round.
Grain Meat: Focusing on whole cut plant-based meat
With its proprietary fiber weaving technique and specially-designed machinery, Wuxi-based Grain Meat aims to replicate the texture and even the grain of real meat
Zhenmeat: Offering a modern plant-based meat alternative in China
The Chinese startup is providing a product adapted for Chinese tastes in an emerging market.
Plant-based meat faces backlash in China despite gaining traction
An innocuous video clip sparked debate on social media over plant-based meat, with suspicion about its nutritional value, cost-effectiveness and even the motives of foreign companies
Do plant-based meat alternatives stand a chance in China, the world's largest meat consumer?
Major food brands and foodtech startups are trying to build their following in a nascent market forecast to grow to nearly $12bn worth by 2023
Indonesia's Green Rebel Foods to take its Asian-inspired plant-based meat regional
F&B veteran duo behind the Burgreens spinoff plans Series A fundraising by end-2021 for manufacturing and regional expansion
In a nascent market, one-year-old Starfield has brought its offerings to around 3,000 F&B outlets and generated RMB 10m in revenue
SWITCH Singapore: Alternative protein sure to take off in Asia, with Singapore as innovation hotbed
In an in-depth discussion, food industry experts say products made with alternative protein in hybrid forms could offer the fastest route to commercialization
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
Yali Bio: Recreating a juicy steak in plant-based alternatives
Founded by the former head of Impossible Foods’ pilot plant, this Bay Area genomics and foodtech startup is one of the first to engineer a better fat for plant-based meat
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Novameat: 3D printing tech to develop meat substitute products
Italian scientist Giuseppe Scionti has repurposed bioprinting technology used to create an artificial human ear to develop a plant-based "steak"
China a “positive environment” for uptake of cultured meat, researcher tells Future Food Asia
But for interested cultured meat companies, China-based Chloe Dempsey suggests it would be better to wait, observe and learn more about the market before trying to tap its massive potential
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
NotCo: Will this Bezos-backed plant-based foodtech be Chile's first unicorn?
Armed with $85m Series C funding, NotCo has expanded to the US, competing head-on with popular US alt-protein brands for a foothold in the multibillion-dollar vegan market
Sorry, we couldn’t find any matches for “Plant-based meat”.
POPULAR DATABASE
